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Abstract 
Background: Ipomoea aquatica (Convolvulaceae) and Enhydra fluctuans (Asteraceae), two aquatic vegetables, are 
traditionally used against heavy metal toxicity in traditional medicines in India. The present study aimed to explore the 
protective role of edible (aqueous) extracts of I. aquatica (AEIA) and E. fluctuans (AEEF) against Cd‑intoxication.
Methods: The extracts were chemically standardized by spectroscopic and HPLC analysis. The cytoprotective roles 
of AEIA and AEEF were measured on mouse hepatocytes. The effect on redox status were measured after incubating 
the hepatocytes with CdCl2 (30 μM) along with AEIA or AEEF (400 μg/ml). The effects on the expressions of apoptotic 
signal proteins were estimated. The protective roles of AEIA or AEEF were measured by in vivo assay in mice. Haema‑
tological, serum biochemical, tissue redox status, Cd bioaccumulation and histological parameters were evaluated to 
estimate the protective role of AEIA or AEEF (100 mg/kg) against CdCl2 (4 mg/kg) intoxication.
Results: Phytochemical analysis revealed presence of substantial quantities of phenolics, flavonoids, saponins, car‑
bohydrates and ascorbic acid in AEIA or AEEF. CdCl2 treated murine hepatocytes showed a gradual reduction of cell 
viability in a concentration dependent manner with an IC50 of ~30 μM. CdCl2 treated hepatocytes exhibited signifi‑
cantly enhanced levels (p < 0.01) of ROS production, lipid peroxidation, protein carbonylation and NADPH oxidase 
with concomitant depletion (p < 0.01) of antioxidant enzymes and GSH. However, AEIA or AEEF treatment along with 
CdCl2 significantly restored the aforementioned parameters in murine hepatocytes near to normalcy. Besides, AEIA or 
AEEF significantly counteracted (p < 0.05–0.01) with ROS mediated alteration of transcription levels of signal proteins 
viz. Bcl‑2, BAD, Cyt‑C, Caspases, Fas and Bid. In in vivo bioassay, CdCl2 treatment caused significantly high Cd bioac‑
cumulation and oxidative stress in the liver, kidney, heart, brain and testes in mice. In addition, the haematological and 
serum biochemical parameters were significantly altered in the CdCl2 treated animals. Simultaneous administration of 
AEIA or AEEF could significantly restore the tested parameters to the near‑normal status.
Conclusion: The extracts would offer the overall protective effect via counteracting with Cd mediated oxidative 
stress and/or promoting the elimination of Cd by chelating.
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Background
Cadmium (Cd), a toxic heavy metal, exerts deleterious 
effect to the majority of human organs. With increasing 
industrial and anthropogenic activities, over past few 
decades, emanations of Cd into the environment has 
increased significantly than normal limits [1]. Therefore, 
the risk of Cd exposure is constantly increasing. Sig-
nificantly high half-life, faster absorption and low rate 
of excretion promote the bioaccumulation of Cd above 
toxic level within a short span of time [2, 3]. In chronic 
exposure, Cd has been considered to be a multi-target 
toxicant, and it causes damage of vital organs namely 
liver, kidney, heart, brain and testes [4]. The exact mech-
anism of Cd toxicity is not quite clear, however, Cd 
mediated free radical generation is proposed to be the 
principle mechanism of Cd pathogenesis [5]. The reactive 
oxygen species (ROS) directly react with cellular macro-
molecules mainly lipids, proteins and nucleic acids and 
that can ultimately lead to cell death [5, 6]. Besides, ROS 
activates NADPH oxidase [7] and mitochondrial dys-
function, both participate in the apoptotic events within 
the tissues [8]. Considering the mechanisms of Cd tox-
icity, it would be important to consider antioxidants to 
counteract with these toxic manifestations. Initially, vari-
ous types of metal chelating agents and antagonists have 
been exploited to counteract with Cd toxicity, however, 
several undesirable side effects and contraindications 
have largely restricted their applications [9]. On other 
hand, many of edible plants are known to possess sig-
nificant antioxidant activities, as they are rich in phyto-
antioxidants [10]. Therefore, dietary antioxidants would 
offer a protective role against Cd toxicity. Because of 
easy availability, low cost and no side effect, dietary anti-
oxidants would have huge scope to serve as a therapy of 
Cd-intoxication.
Ipomoea aquatica Forssk. (Convolvulaceae) and Enhy-
dra fluctuans Lour. (Asteraceae) are two aquatic veg-
etables distributed in Southern Asia, India, and China. 
These are commonly consumed as green leafy vegetables 
and they have high nutritive values to human beings. I. 
aquatica has been used in folk medicine against differ-
ent diseases including diabetes [11], hypertension [12], 
liver malfunction [13], constipation [14] and in the treat-
ment of opium and arsenic poisoning [15]. On other 
hand, E. fluctuans possesses ethnomedicinal significance 
as anti-inflammatory [16], anthelmintic [16], analgesic 
[17], hepatoprotective [18] and hypotensive [18] agent. 
A Literature survey revealed presence of flavonoids, phe-
nolic compounds, β-carotene and ascorbic acid in both 
the plants [18, 19]. Considering the presence of phyto-
antioxidant molecules, the present study was designed to 
evaluate the possible protective role of aqueous extracts 
of the two aforementioned edible plants in Cd-toxicity. A 
suitable in vitro model (on isolated murine hepatocytes) 
was used to study the effect of the extracts against Cd-
toxicity on isolated cells. Cell viability was measured to 
assess the cyto-protective role of the extracts. The effects 
of test materials on markers exhibiting cellular redox sta-
tus were estimated. In addition, the expressions of redox 
sensitive transcription proteins were examined in mouse 
hepatocytes in absence and presence of test extracts. 
Based on in vitro results, we have tested the test materi-
als in vivo. Haematological, biochemical and redox mark-
ers were estimated in vivo in experimental mice. Finally, 
histological studies were performed to show the overall 




The 1-chloro-2,4-dinitrobenzene, ammonium sulphate, 
2,4-dinitrophenylhydrazine, ethylene diaminetetraacetic 
acid, 5,5-dithiobis(2-nitrobenzoic acid), N-ethylmaleim-
ide, nitroblue tetrazolium, reduced nicotinamide adenine 
dinucleotide, potassium dihydrogen phosphate, phena-
zinemethosulphate, sodium pyrophosphate, reduced 
glutathione, sodium azide, thiobarbituric acid, 5-thio-
2-nitrobenzoic acid and trichloro acetic acid were pur-
chased from Sisco Research Laboratory, Mumbai, India. 
Bradford reagent, bovine serum albumin and cadmium 
chloride were procured from Sigma-Aldrich Chemical 
Company, St. Louis, USA. All antibodies for immunob-
lotting were purchased from Sigma-Aldrich Chemical 
Company St. Louis, USA. HPLC grade solvents (acetic 
acid, formic acid, methanol and acetonitrile) were pro-
cured from Merck, Mumbai, India.
Preparation of extract
Aerial parts of I. aquatica and E. fluctuans were collected 
in the month of September, 2012 from West Midnapore, 
India. The plants were authenticated by the Taxonomists, 
Botanical Survey of India, Howrah, India. The voucher 
specimens JU/PT/PC/07/12 and JU/PT/PC/09/12  have 
been deposited at Advanced Pharmacognosy Research 
Laboratory. The plants were dried in an incubator 
(40 ± 5°C, for 72 h) and pulverized into fine powder. The 
powdered plant materials were macerated with double 
distilled water containing 1% chloroform (v/v) for 48  h 
at 30  ±  5°C with continuous stirring. Addition of 1% 
chloroform ensures protection against microbial growth 
within the aqueous system without affecting polarity. The 
extracts were filtered to remove particulate matters and 
lyophilized (Heto FD 3 Drywinner, Allerod, Denmark) to 
yield the powdered crude extracts AEIA (~11.7%, w/w) 
and AEEF (~12.5%, w/w). The testing samples were pre-
pared by dissolving lyophilized powder in distilled water 
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containing 1% tween 80 (v/v) prior to in vivo experiment, 
whereas for in  vitro assay, the extracts were solubilized 
in DMSO and diluted with autoclaved water into desired 
concentration (resultant ≤0.4% DMSO in contact to cells 
to avoid DMSO induced cytotoxicity).
Phytochemical analysis
Quantitative analysis for phytochemicals present within 
the extracts (AEIA and AEEF) was determined spec-
trophotometrically by evaluating total flavonoids [21], 
total phenolics [22], total saponins [23] and total carbo-
hydrates [24] content. The identification of individual 
phenolic and flavonoid compounds was done in Dionex 
Ultimate 3000 HPLC system (Dionex, Germany), using a 
reverse phase C-18 column (250 × 4.6 mm, particle size 
5µ) and UV detector. Methanol (HPLC grade) was used 
to prepare samples which were later filtered by cellulose 
nylon membrane filter (0.45 µm). The aliquots of the fil-
trate were eluted with an isocratic solvent mixture com-
prising methanol: acetonitrile: acetic acid: o-phosphoric 
acid: water (20:10:1:1:20) for flavonoids, methanol: water: 
acetic acid (75:24:1) for phenolic compounds and 25 mM 
phosphate buffer (pH 3.0 with phosphoric acid) for 
ascorbic acid with the flow rate of 1 ml/min and detected 
at 352, 254 and 230  nm, respectively. The quantity of 
ascorbic acid within the extracts was estimated by HPLC 
analysis.
Animals
Healthy Swiss albino mice (♂) of age between 1 and 
2 months, weighing between 20 and 30 g were employed 
in this study. Animals were maintained under stand-
ard laboratory conditions of temperature (25  ±  2°C), 
relative humidity (50  ±  15%), 12  h light–dark cycle, 
standard diet and water ad  libitum. The principles of 
Laboratory Animals care [25] and the instructions given 
by our institutional animal ethical committee (Reg no 




The mice were subjected to CO2 euthanasia and sac-
rificed by cervical dislocation. The livers were excised, 
cleaned and washed with phosphate buffer saline (pH 
7.4). Hepatocytes were isolated from mouse liver by the 
method of Sarkar and co-workers [26] with little modifi-
cations. Briefly, hepatocytes were isolated by collagenase 
perfusion followed by mechanical disruption. Hepato-
cytes (~90% viability) were passed through a wide bore 
syringe, filtered and centrifuged (500  rpm) for 5  min. 
The pellet was resuspended in Dulbecco’s Modified 
Eagle Medium containing 10% Fetal bovine serum and 
incubated at 37°C and 5% CO2 tension to achieve mon-
olayer in the culture flask.
Determination of cytotoxic effect of CdCl2
Concentration dependent cytotoxic effect of CdCl2 was 
determined by cell viability assay. Briefly, different sets 
of hepatocytes (~2 ×  106 cells/set) were incubated with 
CdCl2 (0.25–10,000 µM) at 37°C and 5% CO2 tension for 
2 h. The percents of viable cells were counted using MTT 
(3-(4, 5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium 
bromide) assay [27].
Assessment of cytoprotective role of AEIA and AEEF
A cell viability assay has been performed to measure cyto-
protective role of extracts (AEIA and AEEF) against Cd-
induced cytotoxicity. Briefly, different sets of hepatocytes 
(~2 ×  106 cells/set) were incubated at 37°C with CdCl2 
(30 µM) and CdCl2 (30 µM) along with the extracts (50, 
100, 200 and 400  µg/ml) for different times (0.5  h, 1  h, 
1.5 h, 2 h, 2.5 h and 3 h). The concentration of CdCl2 was 
chosen on the basis of IC50 value (~30 µM) of CdCl2 in 
isolated murine hepatocytes. The cell viability was deter-
mined as by the MTT assay [27]. One set without CdCl2 
was kept as normal control. Two sets of cells treated with 
highest concentration of either of test extracts (400  µg/
ml) (without CdCl2) were kept to ensure that the test 
extracts are non-toxic to isolated murine hepatocytes.
Flow cytometric analysis
The flow cytometric analysis has been performed to 
determine the nature of death. Briefly, CdCl2 at a dose 
of 30 µM (in presence or absence of AEIA or AEEF at a 
dose of 400 µg/ml) were incubated for 3 h at 37°C. The 
doses of Cd and extracts were selected on the basis of the 
observation of cell viability assay. One set without CdCl2 
was kept as normal control. The hepatocytes were treated 
with propidium iodide (PI) and FITC-labelled Annexin 
V for 30 min at 37°C. After washing of excess of PI and 
Annexin V; cells were fixed and analysed by flow cytom-
etry using FACS Calibur (Becton–Dickinson, Moun-
tain View, USA) equipped with 488 nm argon laser light 
source; 515  nm band pass filter for FITC-fluorescence 
and 623  nm band pass filter for PI-fluorescence using 
Cell Quest software. A scatter plot of PI-fluorescence vs 
FITC-fluorescence has been prepared.
Hoechst staining
Hoechst staining was performed to detect cell viability by 
staining nucleus under fluorescence microscopy. Briefly, 
2,000 cells/well were cultured in tissue culture plate and 
incubated at 37°C and 5% CO2. 24  h after seeding, the 
cells were incubated with CdCl2 + AEIA or AEEF. After 
2 h, the cells were fixed in 4% paraformaldehyde in PBS 
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for 25  min. Fixed cells were incubated with Hoechst 
33258 (5  μg/ml in PBS) for 15  min. Fluorescent nuclei 
were scored as an index of cell viability.
Assays of antioxidant markers
Different sets of hepatocytes, each containing 1  ml of 
suspension (~2 × 106 cells/ml) were used in the experi-
ments. The protective role of AEIA or AEEF in CdCl2-
intoxication was analyzed by incubating hepatocytes with 
extracts and CdCl2 together for 2 h at 37°C [2]. Hepato-
cytes were incubated for 2  h with CdCl2 to act as toxic 
control. One set without any treatment was kept as con-
trol. Generation of intracellular ROS was quantified by a 
previously reported method of LeBel and Bondy [28] with 
little modification introduced by Kim and co-workers 
[29] and 2′,7′-dichlorofluorescein-formation was meas-
ured by using a fluorescence spectrometer (HITACHI, 
Model No. F4500, Japan) at the excitation and emis-
sion wavelengths of 488  nm and 510  nm, respectively. 
NADPH oxidase activity was analyzed by the method 
described previously [30]. The extent of lipid peroxida-
tion i.e. thiobarbituric acid reactive substances (TBARS) 
were measured by the method described by Ohkawa 
et  al. [31]. The protein carbonylation was determined 
according to the method of Uchida and Stadtman [32]. 
The antioxidant enzymes superoxide dismutase (SOD), 
catalase (CAT), glutathione-S-transferase (GST), glu-
tathione peroxidase (GPx), glutathione reductase (GR) 
and glutathione-6-phosphate dehydrogenase (G6PD) 
activity was measured according to the method described 
by Ghosh and co-workers [20]. Non-enzymatic antioxi-
dant, reduced glutathione (GSH), level was assayed by 
the method of Hissin and Hilf [33].
Immunoblotting of signaling proteins
Samples containing proteins (20  µg) were subjected to 
SDS-PAGE (12%) and transferred to a nitrocellulose 
membrane using standard dry transfer method. Mem-
branes were blocked (4°C;1 h) in blocking buffer contain-
ing non-fat dry milk (5%) to prevent non-specific binding 
and were washed with tris-buffered saline (TBS) with 
0.1% Tween 20 (pH 7.6) with gentle shaking. Then the 
membranes were incubated with primary antibodies viz. 
anti-caspase 3 (1:1,000 dilution), anti-caspase 9 (1:1,000), 
anti-caspase 8 (1:1,000), anti-P65 NF-κB (1:1,000), anti-
JNK (1: 1,000), anti-phospho-p38 (1: 1,000), anti-Bad 
(1:2,000), anti-Bcl-2 (1:2,000 dilution), anti-Fas (1: 1,000), 
anti-Bid (1: 1,000), anti-cyt C (1: 1,000) at 4°C over-
night. The membranes were washed with Tris-buffered 
saline (TBS) with 0.1% Tween 20 (pH 7.6) with gentle 
shaking, incubated with appropriate HRP conjugated 
secondary antibody (1:3,000 dilution) for 1  h at room 
temperature and developed by the HRP substrate 3, 




Twenty four Swiss albino mice were divided into four 
groups (n = 6) and they were treated as follows:
Group I: Normal control (animals received only double 
distilled water as vehicle);
Group II: Toxic control (animals received CdCl2 
through double distilled water at a dose of 4 mg/kg body 
weight, p.o. for 6 days, once daily) [5];
Group III: Animals were treated with AEIA (100 mg/kg 
body weight, p.o.) for 5 days followed by CdCl2 (4 mg/kg 
body weight, p.o., once daily) intoxication for next 6 days 
[5];
Group IV: Animals were treated with AEEF (100 mg/kg 
body weight, p.o.) for 5 days followed by CdCl2 (4 mg/kg 
body weight, p.o., once daily) intoxication for next 6 days 
[5];
The in vivo experimental schema has been depicted in 
Fig. 1. The selection of doses was based on the observa-
tion of in vitro assay and the preliminary assay conducted 
in our laboratory. In this manuscript, we mentioned only 
optimum doses of extracts to show their comparative 
effectiveness. The dose of CdCl2 was chosen on the basis 
of acute toxicity study in experimental mice. The LD50 
value was found to be ~4 mg/kg. After 11 days, the ani-
mals were subjected to CO2 euthanasia and sacrificed by 
cervical dislocation. Before sacrificing the animals, blood 
samples were collected from retro-orbital venous plexus 
in Eppendorf tubes rinsed with anticoagulant for haema-
tological assays. The organs (Liver, kidney, brain, heart 
and testes) were excised, cleaned and washed with phos-
phate buffer saline (pH 7.4). The organs were homog-
enized in 0.1 M Tris–HCl-0.001 M EDTA buffer (pH 7.4) 
and centrifuged at 12,000 g for 30 min at 4°C. The super-
natant were collected and used for assaying biochemical 
parameters.
Haematological parameters
The total erythrocytes count and haemoglobin content 
were determined by using standard laboratory proce-
dures. Serum biochemical parameters viz. alanine ami-
notransferase (ALT) and aspartate aminotransferase 
(AST), urea, cholesterol and triglycerides were estimated 
by standard kits (Span Diagnostic Limited, India).
Assessment of antioxidant markers related to organ 
dysfunction
Distribution of Cd in tissues has been measured by 
flame atomic absorption spectroscopy. The intercellu-
lar ROS, NADPH, TBARS level, antioxidant enzymes, 
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non-enzymatic antioxidant were assayed following stand-
ard assay protocols mentioned earlier. Co-enzymes Q (Q9 
and Q10) were isolated and estimated according to the 
method of Zhang and co-workers [34].
Histological studies
The organs from the normal and experimental mice were 
fixed in 10% buffered formalin and were processed for 
paraffin sectioning. Sections of about 5  μm thickness 
were stained with hematoxylin and eosin to study the his-
tology of organs of all experimental animals [35].
Statistical analysis
Data were statistically examined by one way ANOVA and 
reported as mean ± SE followed by Dunnett’s t test using 
GraphPad InStat software, version 3.05, U.S.A. The val-
ues were considered significant when p < 0.05.
Results
Phytochemical analysis
Quantities of phytochemicals were depicted in Fig.  2a.
The identification of phenolic compounds and flavonoids 
were done by RP-HPLC analysis and comparing reten-
tion time (Rt) and UV spectra with standard flavonoids 
and phenolic compounds. HPLC analysis revealed pres-
ence of flavonoids namely myricetin, quercetin and api-
genin in AEIA, while, HPLC analysis reported presence 
of myricetin and quercetin in AEEF (Fig. 2b). In search of 
phenolic compounds, both the extracts showed presence 
of gallic acid and chlorogenic acid (Fig.  2c). Significant 
quantities of ascorbic acid in AEIA and AEEF (Fig.  2d) 
were also detected.
Effect of AEIA and AEEF in Cd toxicity in isolated murine 
hepatocytes
Effect on Cd induced cytotoxicity
Cell viability is an important indicator of finding the 
degree of cytotoxicity, caused by any toxicant. Figure 3a 
depicts the dose dependent effect of CdCl2 in isolated 
murine hepatocytes. Hepatocytes incubated with CdCl2 
(0.25–10,000 μM) for 2 h exhibited the reduction in cell 
viability in a concentration dependant manner. The IC50 
value was found to be 31.2 μM (~30 μM). Figure  3b, c 
depicted the protective role of AEIA and AEEF in CdCl2 
induced cytotoxicity in isolated murine hepatocytes, 
respectively. The simultaneous treatment of hepato-
cytes with AEIA and AEEF (50, 100, 200 and 400 µg/ml) 
(30 µM) prevented the CdCl2 mediated reduction in cell 
viability up to 3  h in a concentration dependent man-
ner. The best cytoprotective role was found at the dose 
of 400 µg/ml in either of extract. AEIA (400 µg/ml) and 
AEEF (400  µg/ml) could restore cell viability of ~77.5 
and 74.3% at 3 h, respectively. However, the cells treated 
with CdCl2 (30  µM) alone exhibited gradual reduction 
of cell viability up to 3 h. On other hand, the untreated 
murine hepatocytes (control) were kept as control and 
linearly restore cell viability throughout the course of 
study (~98%). The cells treated with the individual extract 
AEIA/AEEF (-) CdCl2 (-) 
Gr I: Normal 
control (n=6) 
                             Experimental schedule  (Day)
1 2 3 4 5           6 7 8 9 10 11          12
Gr II: Toxic 
control (n=6) AEIA/AEEF (-) CdCl2 (+) 
Gr III (n=6) AEIA (+) CdCl2 (+) 






4 mg/kg, p.o. 
4 mg/kg, p.o. 
4 mg/kg, p.o. 
100 mg/kg, p.o. 
100 mg/kg, p.o. 
Fig. 1 Schematic presentation of in vivo experimental protocol. ‘−’ means untreated, ‘+’ means treated.
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(without CdCl2) maintained almost similar pattern of via-
bility up to 3 h as compared with control group.
To investigate the nature of cell death, hepatocytes 
were assessed by flow cytometric analysis. Flow cyto-
metric data (Fig.  3d) revealed that, in comparison to 
control, Cd-intoxicated hepatocytes showed maxi-
mum Annexin V-FITC-binding (~38.5%), but very 
little PI staining (~1.2%) indicating majority of cells 
were apoptotic. In AEIA and AEEF treated hepato-
cytes, the number of apoptotic cells was significantly 
low (~14.2 and 15.1%, respectively) indicating a pos-
sible cytoprotective role of AEIA and AEEF from Cd-
induced apoptosis. While, control group showed very 
little apoptotic (~0.08%) cells as compared with viable 
cells (~99.1%).
The cytoprotective effect of AEIA and AEEF was con-
firmed by fluorescence microcopy after Hoechst stain-
ing (Fig.  3e) of hepatocytes under different treatments. 
CdCl2 treated hepatocytes exhibited significantly less 
number of visible nuclei, however, the visible nuclei 
exhibited distinct pattern of morphological changes 
as compared with normal hepatocytes. The simulta-
neous incubation of hepatocytes with AEIA or AEEF 
along with CdCl2 significantly counteracted with cyto-
toxic effect of CdCl2 confirmed by nuclear scoring and 
morphology.
Fig. 2 Phytochemical analysis of AEIA and AEEF. a Quantitative analysis of AEIA and AEEF. Values are expressed as mean ± SE. b Representative 
HPLC chromatograph of standard flavonoids viz. myricetin (Rt: 4.08) quercetin (Rt: 5.70) and apigenin (Rt: 8.16) and flavonoids in AEIA and AEEF. c 
Representative HPLC chromatograph of standard phenolic compounds viz. gallic acid (Rt: 4.03) and chlorogenic acid (Rt: 7.24) and phenolic com‑
pounds in AEIA and AEEF. d Representative HPLC chromatograph of standard ascorbic acid (Rt: 3.91) and ascorbic acid in AEIA and AEEF.
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Fig. 3 Cell viability studies in absence (CdCl2) and presence of AEIA OR AEEF in vitro. a Effect of CdCl2 at different concentrations in cell viability 
in isolated mouse hepatocytes. b Time and dose‑dependent effect on cell viability in absence (CdCl2) and presence of AEIA (A) in isolated murine 
hepatocytes. c Time and dose‑dependent effect on cell viability in absence (CdCl2) and presence of AEEF (a) in isolated murine hepatocytes.Values 
are expressed as mean ± SE (n = 3). #Values differ significantly (p < 0.01) from normal control. *Values differ significantly (p < 0.05) from toxic con‑
trol. **Values differs significantly (p < 0.01) from toxic control. **Values differ significantly (p < 0.001) from toxic control. d Percentage distribution of 
apoptotic and necrotic cells in absence (CdCl2) and presence of AEIA or AEEF by flow cytometric analysis. e Hoechst staining of murine hepatocytes 
in absence (CdCl2) and presence of AEIA and AEEF.
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Effect on CdCl2 induced alteration of antioxidant markers 
in isolated murine hepatocytes
Table 1 represents the effects of AEIA and AEEF against 
CdCl2 induced alteration of antioxidant markers in iso-
lated mouse hepatocytes. The extent of lipid peroxida-
tion (TBARS) and protein carbonylation was significantly 
enhanced (p  <  0.01) in Cd-intoxicated hepatocytes. The 
extent of lipid peroxidation (p  <  0.05) and protein car-
bonylation (p < 0.01) was significantly reduced by simul-
taneous treatment with AEIA or AEEF. The levels of 
CAT, SOD, GST, GPx, GR, G6PD, GR and GSH were sig-
nificantly reduced (p < 0.01) in CdCl2 intoxicated hepato-
cytes. Simultaneous treatment of the extracts along with 
CdCl2 significantly reverted (p < 0.05–0.01) the levels of 
aforementioned antioxidant enzymes and GSH to near-
normal status. Excessive regeneration of ROS during Cd-
intoxication is associated with the activation of NADPH 
oxidases. Figure 4a, b confirmed the enhanced (p < 0.01) 
production of ROS and NADPH in hepatocytes during 
Cd-intoxication, respectively. However, simultaneous 
incubation with AEIA or AEEF significantly (p  <  0.01) 
inhibited ROS and NADPH oxidases levels in murine 
hepatocytes. 
Effect on CdCl2 induced alteration of signaling proteins
The activation of NADPH oxidases is associated with 
simultaneous increment in P47 phosphorylation and 
activation of JNK phophorilation. Later plays an impor-
tant role in the event of apoptosis. In this study, a sig-
nificant up-regulation (p  <  0.01) of phosphorylated P47 
was observed in western blot analysis of Cd-intoxicated 
murine hepatocytes (Fig. 4c). A significant up-regulation 
(p  <  0.01) of phosphorylated-JNK (both 54 and 46 kD 
proteins) over total JNK (both 54 and 46 kD proteins) 
was recorded in CdCl2 treated hepatocytes (Fig.  4d). 
Incubation of hepatocytes with the AEIA or AEEF, how-
ever, significantly arrested the phosphorylation of P47 
(p  <  0.05) and JNK (p  <  0.01–0.05) in isolated murine 
hepatocytes. Apoptosis is regulated by a complex interac-
tion of anti-apoptotic and pro-apoptotic proteins follow-
ing the activation of caspases. Immunoblotting results 
suggested that CdCl2 up-regulated the translocation of 
pro-apoptotic Bad in mitochondria from cytoplasm. 
Figure  5a depicted that an increase in the expression of 
Bad protein in mitochondria with concomitant down-reg-
ulation of Bad expression in cytosol resulting a significant 
higher (p  <  0.01) mitochondrial Bad/cytosolic Bad over 
control. However, incubation of hepatocytes with AEIA 
or AEEF significantly (p < 0.05) reverted these alterations 
near to normalcy. The anti-apoptotic Bcl-2 protein was 
significantly down regulated following Cd-intoxication, 
which resulted a significant increase (p  <  0.01) in mito-
chondrial Bad/Bcl-2 ratio (Fig.  5b). However, incubation 
of hepatocytes with AEIA or AEEF significantly (p < 0.05) 
reinstated these alterations to near-normal status. To 
investigate the pro-apoptotic effect of P65 NF-κB in Cd-
induced hepatocyte injury, immunoblot analysis of P65 
NF-κB showed that CdCl2 exposure caused a signifi-
cant (p  <  0.01) increase in the expression of P65 NF-κB 
(Fig.  5c). However, simultaneous incubation of hepato-
cytes with AEIA or AEEF significantly (p < 0.05) reduced 
the expression of P65 NF-κB as compared to toxic con-
trol group. The increase in the expressions of cytosolic 
Cyt C in association with activation of cleaved caspase 3 
and 9, demonstrated the association of the mitochondria 
dependent (intrinsic) apoptotic pathway. In this study, 
an increase in the expressions of cytosolic Cyt C with 
simultaneous reduction of mitochondrial Cyt C resulted 
a significant (p < 0.01) increase in cytosolic Cyt C/mito-
chondrial Cyt C (Fig. 5d). In this study, the expressions of 
Table 1 Effect on  antioxidant parameters in  absence (CdCl2) and  presence of  AEIA (AEIA  +  CdCl2) and  AEEF 
(AEEF + CdCl2) in isolated mice hepatocytes
Values are expressed as mean ± SE (n = 3). # Values differ significantly from normal control (p < 0.01). $ Values differ significantly from normal control (p < 0.05). 
* Values differ significantly from CdCl2 control (p < 0.05). ** Values differ significantly from CdCl2 control (p < 0.01). CAT unit, ‘U’ is defined as µmoles of H2O2 consumed 
per minute. SOD unit, ‘U’ is defined as the µmoles inhibition of NBT reduction per minute.





TBARS (µg/g of tissue) 3.65 ± 0.24 6.89 ± 0.54# 4.89 ± 0.45* 5.11 ± 0.51*
Protein carbonyl (nmol/mg of protein) 41.75 ± 4.24 76.54 ± 5.33# 52.82 ± 4.79** 54.11 ± 3.96**
CAT (U/mg of protein) 234.56 ± 14.33 168.67 ± 10.89# 234.56 ± 14.92** 228.92 ± 12.78*
SOD (U/mg of protein) 86.54 ± 4.12 55.54 ± 3.96# 75.44 ± 4.06** 72.12 ± 4.35*
GST (µmol/h/mg protein) 0.92 ± 0.11 0.54 ± 0.07$ 0.88 ± 0.09* 0.83 ± 0.07
GPx (nmol/min/mg of protein) 76.67 ± 4.12 51.78 ± 3.50# 71.58 ± 4.21** 67.43 ± 3.98**
GR (nmol/min/mg of protein) 82.01 ± 4.45 54.15 ± 3.92# 72.67 ± 4.05* 70.84 ± 4.96*
G6PD (nmol/min/mg of protein) 116.12 ± 5.56 75.60 ± 4.85# 104.78 ± 5.11** 101.96 ± 4.76**
GSH (nmol/mg of protein) 5.23 ± 0.47 3.12 ± 0.34# 4.81 ± 0.40* 4.67 ± 0.33*
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cleaved fraction of caspase 9 and 3 were up-regulated in 
the CdCl2 intoxicated hepatocytes when compared with 
controlled hepatocytes (Fig.  5e, f, respectively). It sug-
gested the cleavage of pro-caspase 9 and 3 into respective 
cleaved fraction (the expressions of pro-caspase expres-
sion were not shown). However, treatment of hepatocytes 
with AEIA or AEEF significantly (p < 0.05-0.01) reinstated 
the expressions of cleaved caspase 3 and 9, when com-
pared with CdCl2 controlled hepatocytes.
Activation of the extrinsic receptor-mediated pathway 
leads to cause apoptosis via Fas-mediated activation of 
caspase-8 and Bid. Therefore, expression levels of FAS, 
Bid and cleaved caspase 8 have been observed via west-
ern blot analysis. CdCl2 significantly (p < 0.01) up-regu-
lated the expressions of Bid, FAS and cleaved caspase 8 
(Fig.  6) in isolated murine hepatocytes. Simultaneous 
treatment of the cells with AEIA or AEEF, however, sig-
nificantly reduced the expressions of Fas (p < 0.01), Bid 
(p  <  0.05) and cleaved caspase 8 (p  <  0.05-0.01) when 
compared with CdCl2 treated hepatocytes and restore 
the expressions near-normal status.
Effect of AEIA and AEEF against CdCl2 intoxication 
in experimental mice
Effect on haematological and serum biochemical parameters
The effects of different treatments on haematological 
and serum biochemical parameters are shown in Table 2. 
The haematological parameters showed a significant 
(p < 0.01) reduction in total erythrocyte counts and hae-
moglobin content in CdCl2 treated animals (group II). 
AEIA and AEEF supplementation significantly reverted 
the total erythrocyte counts (p < 0.01) and haemoglobin 
content (p  <  0.05). Animals treated with CdCl2 showed 
a significant (p  <  0.01) increase in AST, ALT, urea, tri-
glyceride levels, whereas, the levels of HDL cholesterol 
was found to decrease significantly (p  <  0.01). Animals 
Fig. 4 Effect on ROS production, NADPH oxidase system, phospho‑P47 and JNK status in absence (CdCl2) and presence of AEIA and AEEF in vitro. 
Effect on intercellular ROS production (a). Effect on NADPH oxidase system (b). Respective western blot analysis of phospho‑P47 (c) and phospho‑
rylated‑JNK and total JNK (d) followed by densitometric analysis of the respective protein levels (bottom) and the normal control band was given 
an arbitrary value of 1. β‑actin was used as a loading protein. Values are expressed as mean ± SE (n = 3). #Values differ significantly (p < 0.01) from 
normal control. *Values differ significantly (p < 0.05) from toxic control. **Values differ significantly (p < 0.01) from toxic control.
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Fig. 5 Respective western blot analysis of translocation of Bad to mitochondria (a), Mitrocondrial Bad vs Bcl‑2 (b), P65 NF‑κB (c), cytosolic vs 
mitochondrial Cyt C (d), cleaved caspase 9 (e) and 3 (f) in absence (CdCl2) and presence of AEIA and AEEF followed by densitometric analysis of 
the respective protein levels (bottom). The normal control band was given an arbitrary value of 1. β‑actin was used as a loading protein. Values are 
expressed as mean ± SE (n = 3). #Values differ significantly (p < 0.01) from normal control. *Values differ significantly (p < 0.05) from toxic control. 
**Values differ significantly (p < 0.01) from toxic control.
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received the combined treatment of extracts and CdCl2 
showed significant improvements (p  <  0.05-0.01) in all 
the biochemical parameters tested.
Effect of AEIA and AEEF in Cd bioaccumulation
The effects of different treatments in intracellular Cd bur-
den are shown in Table 3. Exposure to CdCl2 in mice sig-
nificantly (p < 0.01) increased the bioaccumulation of Cd 
in kidney, liver, heart, brain and testes, as compared to 
untreated animals (group I). The order of intracellular Cd 
content was kidney > heart > testes > liver > brain. Treat-
ment of AEIA and AEEF significantly (p  <  0.05-0.01) 
prevented intracellular Cd burden in aforementioned tis-
sues, as compared to CdCl2 treated animals (group II).
Effect on ROS production, lipid peroxidation, protein 
carbonylation and NADPH oxidase
Cd-intoxication caused enhanced (p  <  0.01) accumula-
tion of intercellular ROS in the selected tissues (Table 4). 
AEIA or AEEF treatment prior to Cd administration 
Fig. 6 Respective western blot analysis of Fas, Bid, and caspase 8 in absence (CdCl2) and presence of AEIA and AEEF followed by densitometric 
analysis of the respective protein levels (bottom). The normal control band was given an arbitrary value of 1. β‑actin was used as a loading protein. 
Values are expressed as mean ± SE (n = 3). #Values differ significantly (p < 0.01) from normal control. *Values differ significantly (p < 0.05) from toxic 
control. **Values differ significantly (p < 0.01) from toxic control.
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significantly (p  <  0.05–0.01) prevented the Cd mediated 
ROS generation and subsequent oxidative stress. Protein 
carbonylation and lipid peroxidation are chief indicators 
in oxidative stress-related organ pathophysiology. In this 
study, the extent of lipid peroxidation has been calculated 
by evaluating the concentrations of TBARS in kidney, liver, 
heart, brain and testes of experimental mice (Table  4). 
CdCl2 treated mice (group II) exhibited a significant raise 
(p < 0.01) in TBARS levels, when compared with normal 
control group (group I). The maximum extent of lipid per-
oxidation was found in kidney followed by liver, heart, tes-
tes and brain. AEIA and AEEF supplementation, however, 
significantly prevented that increase in TBARS level in the 
tissues. The extent of protein carbonylation has also been 
significantly increased (p < 0.01) in toxic control mice as 
compared with normal control animals (Table  4). How-
ever, AEIA and AEEF treatment significantly attenuated 
that increase in the levels of protein carbonyl content in 
selected tissues. Cd significantly (p  <  0.01) up-regulated 
NADPH oxidase in the selected tissues of experimental 
mice (Table  4). Simultaneous administration of either of 
AEIA or AEEF significantly (p < 0.05) attenuated NADPH 
oxidase in the selected organs.
Effect on co‑enzymes Q
The effect of various treatments on mitochondrial co-
enzymes Q (Q9 and Q10) in kidney, liver, heart, brain and 
testes has been estimated (Table 4). Total co-enzyme Q9 
and Q10 levels in the selected tissues were significantly 
(p  <  0.01) reduced in CdCl2 treated animals (group II). 
Treatment with AEIA significantly elevated Q9 and Q10 
levels in liver (p < 0.01), kidney (p < 0.01) heart (p < 0.05), 
brain (p  <  0.05) and testes (p  <  0.05). On other hand, 
AEEF treatment significantly elevated Q9 levels in hepatic 
(p < 0.05), renal (p < 0.05) and cerebral (p < 0.05) tissues 
and Q10 levels in hepatic (p < 0.05) and renal (p < 0.05) 
of experimental mice. However, no significant alteration 
of co-enzyme Q9 levels in heart and testes and Q10 levels 
in heart, brain and testes was observed in AEEF + CdCl2 
treated group when compared with toxic control (group 
II).
Effect on antioxidant enzymes and reduced glutathion
The antioxidant enzymes protect biological macromol-
ecules from oxidative damage in oxidative stress. There-
fore, the activities of antioxidant enzymes (CAT, SOD, 
GST, GPx, GR and G6PD) and other cellular metabolites 
Table 2 Effect on  haematological and  serum biochemical parameters in  absence (CdCl2) and  presence of  AEIA 
(AEIA + CdCl2) and AEEF (AEEF + CdCl2) in mice
Values are expressed as mean ± SE, for six animals in each group. # Values differ significantly from normal control (p < 0.01). * Values differ significantly from CdCl2 
control (p < 0.05). ** Values differ significantly from CdCl2 control (p < 0.01). Group I: Normal control; Group II: Toxic control; Group III: AEIA (100 mg/kg) + CdCl2 (4 mg/
kg); Group IV: AEEF (100 mg/kg) + CdCl2 (4 mg/kg).
Parameters Group I Group II Group III Group IV
Total erythrocyte count (×106/mm3) 6.12 ± 0.31 3.25 ± 0.24# 5.05 ± 0.33** 4.78 ± 0.41**
Haemoglobin (g/dl) 8.92 ± 0.85 5.04 ± 0.42# 7.45 ± 0.67* 7.34 ± 0.67*
ALT (IU/l) 84.56 ± 5.11 213.34 ± 17.50# 132.13 ± 12.92** 148.56 ± 13.11**
AST (IU/l) 52.31 ± 3.24 88.35 ± 4.67# 60.89 ± 3.76** 67.33 ± 4.09**
Urea (mg/dl) 25.67 ± 1.89 56.11 ± 2.73# 45.14 ± 2.01** 47.92 ± 2.67*
Total cholesterol (mg/dl) 142.13 ± 6.17 198.34 ± 8.22# 161.45 ± 7.05** 167.96 ± 7.67*
HDL cholesterol (mg/dl) 58.77 ± 3.22 36.92 ± 2.21# 49.87 ± 2.54** 47.21 ± 3.01*
Triglyceride (mg/dl) 125.41 ± 5.12 278.33 ± 11.54# 187.85 ± 8.32** 212.50 ± 7.28**
Table 3 Effect on intracellular Cd burden in liver, kidney, heart, brain and testes in absence (CdCl2) and presence of AEIA 
(AEIA + CdCl2) and AEEF (AEEF + CdCl2) in mice
Values are expressed as mean ± SE, for six animals in each group. # Values differ significantly from normal control (p < 0.01). * Values differ significantly from CdCl2 
control (p < 0.05). ** Values differ significantly from CdCl2 control (p < 0.01). Group I: Normal control; Group II: Toxic control; Group III: AEIA (100 mg/kg) + CdCl2 (4 mg/
kg); Group IV: AEEF (100 mg/kg) + CdCl2 (4 mg/kg).
Groups Cadmium burden (ppm of wet tissue)
Liver Kidney Heart Brain Testes
I 0.07 ± 0.003 0.05 ± 0.007 0.07 ± 0.005 0.04 ± 0.002 0.02 ± 0.003
II 18.56 ± 1.98# 24.67 ± 1.88# 21.32 ± 2.02# 7.23 ± 0.98# 1.23 ± 0.13#
III 9.42 ± 1.62** 15.04 ± 1.72** 12.34 ± 1.89** 4.12 ± 0.83* 0.85 ± 0.07*
IV 11.21 ± 1.89* 17.33 ± 1.46** 14.02 ± 1.84* 4.41 ± 0.72* 0.91 ± 0.09*
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(GSH) have been estimated in this study (Table 5). CAT 
levels were significantly decreased in liver (p < 0.01), kid-
ney (p < 0.01), heart (p < 0.01), brain (p < 0.01) and testes 
(p < 0.05) of CdCl2 treated mice (group II) as compared 
with normal mice (group I). However, treatment with 
AEIA significantly (p < 0.05-0.01) increased CAT activi-
ties in aforementioned tissues, while AEEF improved 
CAT levels in hepatic (p  <  0.05), renal (p  <  0.05) and 
cardiac (p  <  0.05) tissues significantly. In the study of 
SOD activities, a significant (p < 0.05-0.01) depletion of 
SOD level was observed in the selected tissues of CdCl2 
intoxicated mice (group II). Treatment with AEIA sig-
nificantly improved hepatic (p  <  0.01), renal (p  <  0.01), 
cardiac (p < 0.05), cerebral (p < 0.05) and testicular SOD 
(p < 0.05) levels. However, AEEF produced positive effect 
in hepatic (p < 0.01), renal (p < 0.05) and cardiac (p < 0.05) 
tissues. In the study of reduced glutathione regulated 
enzymes namely, GST, GPx, G6PD and GR, a signifi-
cant (p < 0.01) reduction in the levels of aforementioned 
enzymes was observed in CdCl2 control mice (group 
II). The treatment of AEIA significantly (p  <  0.05-0.01) 
increased the levels of GST and GPx in all the selected 
tissues. However, AEIA treatment significantly improved 
GR levels in liver (p  <  0.05), kidney (p  <  0.01), heart 
(p < 0.01) and testes (p < 0.05) and G6PD levels in liver 
(p < 0.05), kidney (p < 0.01) and heart (p < 0.05) of exper-
imental mice (group III).  In another side, treatment of 
AEEF significantly (p < 0.05) increase the levels of GST 
and GPx in hepatic, renal, cardiac and testicular tissues. 
However, AEEF treatment significantly improve GR lev-
els in kidney (p < 0.05) and heart (p < 0.05), and G6PD 
levels in liver (p < 0.05) and kidney (p < 0.05) of experi-
mental mice (group IV). CdCl2 intoxication significantly 
(p  <  0.01) reduced GSH levels in the selected tissues of 
experimental mice (group II). However, AEIA treatment 
significantly improved GSH levels in liver (p  <  0.05), 
kidney (p  <  0.01), heart (p  <  0.05), brain (p  <  0.05) and 
testes (p  <  0.05) of experimental mice (group III) when 
compared with toxic control animal (group II). On other 
hand, AEEF treatment improved GSH levels in liver, kid-
ney and testes of experimental mice (group IV) when 
compared with toxic control animal (group II).
Table 4 Effect on  Co-enzymes Q in  liver, kidney, heart, brain  and testes in  absence (CdCl2) and  presence of  AEIA 
(AEIA + CdCl2) and AEEF (AEEF + CdCl2) in mice
Values are expressed as mean ± SE, for six animals in each group. # Values differ significantly from normal control (p < 0.01). $ Values differ significantly from normal 
control (p < 0.01). * Values differ significantly from CdCl2 control (p < 0.05). ** Values differ significantly from CdCl2 control (p < 0.01). Group I: Normal control; Group II: 
Toxic control; Group III: AEIA (100 mg/kg) + CdCl2 (4 mg/kg); Group IV: AEEF (100 mg/kg) + CdCl2 (4 mg/kg).
Parameters Gr Liver Kidney Heart Brain Testes
ROS production (nmol DCF/min/mg of protein) I 28.65 ± 1.67 38.15 ± 2.24 28.15 ± 2.02 33.49 ± 2.23 31.49 ± 1.54
II 78.56 ± 3.92# 86.29 ± 3.48# 64.13 ± 3.69# 67.09 ± 5.12# 71.23 ± 4.28#
III 53.47 ± 2.67** 66.50 ± 4.54** 49.95 ± 3.15* 50.21 ± 3.85* 52.15 ± 3.94**
IV 59.33 ± 3.45** 71.18 ± 4.12* 51.78 ± 3.88* 52.33 ± 3.08* 56.01 ± 3.42*
Lipid peroxidation (TBARS level in μg/g of tissue) I 5.11 ± 0.76 8.76 ± 1.01 4.21 ± 0.58 2.34 ± 0.32 3.22 ± 0.32
II 8.74 ± 0.98# 16.15 ± 2.11# 8.25 ± 0.58# 4.12 ± 0.50# 5.58 ± 0.72#
III 5.86 ± 0.54* 10.24 ± 1.54* 5.02 ± 0.45** 2.67 ± 0.24* 3.61 ± 0.42*
IV 5.94 ± 0.72* 10.58 ± 1.33* 5.21 ± 0.62* 2.86 ± 0.33* 3.78 ± 0.45*
Protein cabonylation (nmol/mg of protein) I 34.56 ± 1.89 4.87 ± 0.54 2.31 ± 0.22 1.92 ± 0.34 1.02 ± 0.12
II 72.13 ± 2.67# 9.76 ± 1.01# 5.02 ± 0.51# 3.87 ± 0.56$ 1.97 ± 0.23#
III 41.32 ± 2.01** 6.65 ± 0.67* 3.28 ± 0.33* 2.24 ± 0.48* 1.32 ± 0.09*
IV 44.56 ± 2.11** 6.89 ± 0.78* 3.41 ± 0.42* 2.29 ± 0.31* 1.38 ± 0.14*
NADPH oxidase (pmol/min/mg of protein) I 0.42 ± 0.03 0.56 ± 0.04 0.67 ± 0.03 0.38 ± 0.02 0.32 ± 0.03
II 3.67 ± 0.55# 4.55 ± 0.67# 3.91 ± 0.40# 2.98 ± 0.33# 3.18 ± 0.28#
III 2.45 ± 0.18* 2.85 ± 0.33* 2.44 ± 0.45* 1.85 ± 0.24* 2.24 ± 0.35*
IV 2.58 ± 0.21* 2.89 ± 0.54* 2.58 ± 0.32* 1.89 ± 0.27* 2.38 ± 0.26
Total coenzyme Q9 (nmol/g of wet tissue) I 178.67 ± 9.14 148.32 ± 6.33 58.24 ± 3.98 28.67 ± 1.72 98.72 ± 4.92
II 124.56 ± 7.33# 112.56 ± 5.59# 39.21 ± 2.21# 17.87 ± 1.08# 66.67 ± 3.90#
III 164.43 ± 8.39** 144.06 ± 6.18** 53.12 ± 2.92* 24.41 ± 1.45* 84.56 ± 4.04*
IV 158.25 ± 7.53* 139.33 ± 5.89* 49.32 ± 2.54 24.18 ± 1.52* 81.31 ± 3.78
Total coenzyme Q10 (nmol/g of wet tissue) I 30.50 ± 2.34 25.67 ± 1.92 27.24 ± 1.98 7.51 ± 0.46 14.21 ± 1.02
II 18.72 ± 1.78# 15.70 ± 1.18# 18.67 ± 1.02# 4.35 ± 0.22# 8.67 ± 0.84#
III 28.33 ± 1.98** 23.65 ± 1.78** 24.89 ± 1.54* 6.12 ± 0.52* 12.33 ± 1.10*
IV 27.65 ± 2.12* 22.04 ± 1.04* 24.10 ± 1.42 5.78 ± 0.42 11.75 ± 0.78
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Effect on histology of organs
The histological assessments of different organs viz. liver, 
kidney, heart, brain and testes have been depicted in 
Fig. 7a–e respectively. The results revealed that the liver 
of CdCl2 treated mice exhibited diffused portal tract and 
hepatocyte focal damage. The histological examination 
of the kidney tissues of the toxic control mice showed 
glomerular hypercellularity and swelling of renal tubules 
when compared with normal control animals. Cd-intox-
ication caused extensive degeneration in cardiac muscle 
following disorganization of normal radiation pattern. 
The histopathological examination of brain of Cd-intox-
icated mice exhibited vacuolated area degenerated tis-
sues and diffused edema as compared to normal control 
mice. Severe degeneration of seminiferous tubules was 
observed in testes of Cd-treated mice with fractional loss 
of spermatogenic cells. However, treatment with AEIA 
or AEEF restored the cellular architectures of aforemen-
tioned organs near to normalcy i.e. comparable to that of 
organ sections of normal control group.
Discussion
Cd possesses pro-oxidant catalytic activity, which leads 
to oxidative damage of membrane lipids by excessive free 
radicals-generation followed by inhibition of the intra-
cellular antioxidant defence system within the system 
[36]. Oxidative stress is known to alter the expressions 
of genes encoding several redox sensitive transcription 
proteins, which is important event in initiation of apop-
tosis in critical organs by both the intrinsic and extrinsic 
pathways. Present study describes the protective role of 
aqueous extract of two edible plants, I. aquatica and E. 
Table 5 Effect on antioxidant enzymes and GSH levels in liver, kidney, heart, brain and testes in absence (CdCl2) and pres-
ence of AEIA (AEIA + CdCl2) and AEEF (AEEF + CdCl2) in mice
Values are expressed as mean ± SE, for six animals in each group. # Values differ significantly from normal control (p < 0.01). $ Values differ significantly from normal 
control (p < 0.05). * Values differ significantly from CdCl2 control (p < 0.05). ** Values differ significantly from CdCl2 control (p < 0.01). Group I: Normal control; Group II: 
Toxic control; Group III: AEIA (100 mg/kg) + CdCl2 (4 mg/kg); Group IV: AEEF (100 mg/kg) + CdCl2 (4 mg/kg).
Parameters Group Liver Kidney Heart Brain Testes
CAT (U/mg of protein) I 312.92 ± 27.65 248.22 ± 21.24 313.24 ± 21.33 94.12 ± 6.67 41.25 ± 3.87
II 178.43 ± 16.86# 128.30 ± 14.04# 192.56 ± 17.04# 46.45 ± 3.92# 25.54 ± 3.01$
III 279.88 ± 25.46** 221.33 ± 23.78** 267.54 ± 16.92* 69.75 ± 6.78* 38.76 ± 2.98*
IV 264.20 ± 27.11* 214.34 ± 17.67* 261.41 ± 18.00* 67.22 ± 5.98 35.43 ± 3.93
SOD (U/mg of protein) I 82.17 ± 7.21 78.02 ± 6.89 134.69 ± 10.17 94.52 ± 6.25 119.42 ± 8.13
II 45.83 ± 4.34# 42.34 ± 4.71# 78.35 ± 8.92# 52.24 ± 5.08# 78.34 ± 7.78$
III 76.51 ± 6.94** 72.86 ± 6.94** 119.85 ± 11.01* 78.92 ± 7.38* 111.85 ± 9.25*
IV 75.33 ± 6.23** 69.87 ± 7.18* 119.61 ± 9.87* 73.05 ± 7.01 103.61 ± 9.96
GST (µmol/h/mg protein) I 1.28 ± 0.18 1.34 ± 0.11 0.64 ± 0.06 1.75 ± 0.15 4.51 ± 0.36
II 0.59 ± 0.07# 0.68 ± 0.05# 0.42 ± 0.03# 1.24 ± 0.09$ 2.45 ± 0.21#
III 1.16 ± 0.14* 1.21 ± 0.10** 0.61 ± 0.04* 1.67 ± 0.09* 3.91 ± 0.40*
IV 1.14 ± 0.09* 1.20 ± 0.08* 0.59 ± 0.05* 1.65 ± 0.12 3.78 ± 0.33*
GPx (nmol/min/mg protein) I 123.85 ± 6.67 43.62 ± 3.78 312.15 ± 16.33 165.43 ± 8.94 162.05 ± 7.65
II 78.50 ± 4.42# 26.95 ± 2.21# 206.96 ± 12.28# 121.35 ± 6.67# 112.33 ± 6.10#
III 108.50 ± 5.33** 39.28 ± 2.89* 278.36 ± 17.82* 155.85 ± 8.12* 148.76 ± 6.05**
IV 102.05 ± 5.12* 38.47 ± 3.01* 272.84 ± 14.95* 148.33 ± 7.33 142.50 ± 7.02*
GR (nmol/min/mg protein) I 88.85 ± 6.33 34.51 ± 2.87 82.17 ± 4.01 48.12 ± 4.49 85.10 ± 4.54
II 61.78 ± 4.18# 19.33 ± 2.02# 42.76 ± 2.19# 28.94 ± 2.86# 52.95 ± 4.20#
III 84.33 ± 8.02* 31.24 ± 2.49** 63.21 ± 3.77** 40.70 ± 3.55 69.43 ± 3.36*
IV 77.36 ± 5.79 29.72 ± 1.92* 58.76 ± 3.54* 38.29 ± 3.02 63.21 ± 4.47
G6PD (nmol/min/mg protein) I 104.32 ± 9.12 86.74 ± 7.12 98.32 ± 5.14 34.68 ± 3.06 54.25 ± 4.72
II 54.31 ± 5.76# 45.17 ± 3.22# 69.28 ± 4.21# 19.43 ± 2.33# 34.56 ± 2.89#
III 86.08 ± 7.11* 72.16 ± 5.15** 89.67 ± 4.75* 26.54 ± 1.76 46.29 ± 3.16
IV 85.33 ± 6.58* 67.21 ± 4.99* 86.23 ± 4.77 25.33 ± 1.58 45.02 ± 3.04
GSH (nmol/mg protein) I 24.21 ± 2.54 16.54 ± 1.01 19.51 ± 2.01 27.12 ± 2.67 17.65 ± 1.87
II 13.21 ± 1.69# 8.33 ± 0.82# 9.34 ± 1.54# 13.25 ± 1.48# 9.67 ± 1.00#
III 21.88 ± 2.05* 13.45 ± 1.15** 15.43 ± 1.67* 18.24 ± 1.92* 15.67 ± 1.24*
IV 21.35 ± 1.90* 12.67 ± 0.98* 14.45 ± 1.48 19.12 ± 1.78 15.02 ± 1.61*
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Fig. 7 Histological sections of different tested organs of experimental mice in absence (CdCl2) and presence of AEIA and AEEF. Untreated mice 
were kept as control to compare the structural changes caused by CdCl2. a Histogram of liver sections; blue and yellow solid arrows represent 
normal portal vein and hepatocytes, respectively; dotted arrows represent the CdCl2 mediated structural changes of portal veins (blue dotted) and 
hepatocytes (yellow dotted). b Histogram of kidney sections; green and red solid arrows represent normal glomerular structures and renal tubules, 
respectively; dotted arrows represent the CdCl2 mediated glomerular hypercellularity (green dotted) and swelling of renal tubules (red dotted). c 
Histogram of heart sections; red solid arrows indicated normal radiating pattern of cardiac muscle; red dotted arrows showed extensive degeneration 
in cardiac muscle during CdCl2‑intoxication. d Histogram of brain sections; blue arrows represent normal cyto‑architecture of brain; dotted arrows 
represent the CdCl2 mediated development of vacuolated area of degenerated tissues (blue dotted) and diffused edema (yellow dotted). e Histogram 
of testes sections; green arrows represent normal seminiferous tubules; green dotted arrows represent CdCl2 mediated marked degeneration in the 
seminiferous tubules in testes section.
fluctuans, against Cd toxicity. Both in  vitro and in  vivo 
models were employed to evaluate the protective role of 
test extracts against Cd-intoxication. The special empha-
sis was given on signaling pathways and evaluation of the 
mechanism of protection. Finally, the activity has been 
correlated with the phytochemical present within the 
extracts.
In this study, CdCl2 treatment caused a significant ele-
vation of oxidative stress in murine hepatocyte followed 
by apoptosis. Earlier studies revealed that oxidative free 
radicals participates crucial role in Cd mediated cellular 
damage and responsible to exert oxidative injury to the 
cellular macromolecules like proteins, lipids and nucleic 
acids [37]. In this study, CdCl2 exerted a significant 
reduction in number of viable cells of murine hepato-
cytes. The flow cytometric analysis confirmed that apop-
tosis is the principle pathway of cellular damage during 
CdCl2 intoxication. Hoechst staining of Cd-intoxicated 
hepatocytes confirmed the observation of cell viability 
assay and induction of apoptosis. Moreover, a signifi-
cantly less number of visible nucleus coupled with dis-
tinct pattern of visible nuclei were noticed in Hoechst 
staining of CdCl2-intoxicated hepatocytes. However, con-
temporaneous incubation of hepatocytes with either of 
extracts could inhibit the apoptosis.
The generation of ROS is thought to be the principle 
mechanism of Cd toxicity. In this study, Cd-mediated 
oxidative stress could be correlated to the increase in 
the levels of lipid peroxidation and protein carbonyla-
tion. However, extract treatment could prevent the 
Cd-induced augmented lipid peroxidation and protein 
carbonylation probably by reducing and/or detoxifying 
several reactive intermediates viz. hypochlorous acid, 
nitric oxide, hydrogen peroxide and hydroxyl radical etc. 
[5]. Presence of dietary antioxidants like phenolic com-
pounds, flavonoids and ascorbic acid would be responsi-
ble for reduction of augmented oxidative stress caused by 
CdCl2.
The generation of ROS during in presense of Cd is 
associated with the activation of NADPH oxidase sys-
tem, which is coupled with an increase in phospho-p47 
[38]. NADPH oxidase uses electrons from intracellular 
NADPH to generate superoxide from molecular oxygen 
[39]. The NADPH oxidase participates in key cellular 
processes, associated with cell-signalling, cell-prolifera-
tion and apoptosis [40]. NADPH oxidase plays an impor-
tant role in apoptosis via up-regulation phospho-JNK 
[20].
Mitochondrial antioxidant enzyme (CAT, SOD, GST, 
GPx, G6PD, GR etc.) system serves as a line of cellular 
defense against oxidative stress [41–43]. On other hand, 
thiol-based antioxidant (GSH) contributes in cellular 
defense against oxidative damage caused by free radicals. 
Depletion of aforementioned cellular redox markers dur-
ing Cd-intoxication may be due to the thiol affinity of Cd 
and/or impairment of electron transfer process [1, 5]. The 
extracts may exert their effect by diverse mechanisms, 
mainly by quenching, addition and/or recombination of 
free radical and electron transfer.
Oxidative stress is a key player in mitochondrial dys-
function which is an important early event of apoptotic 
pathway. A number of apoptosis-inducer proteins are 
up-regulated in presence of oxidative radicals. Apoptotic 
pathways are executed by some pro-apoptotic (Bad) and 
anti-apoptotic (Bcl-2) proteins and caspases. Bcl-2 fam-
ily members regulate apoptosis via intrinsic pathway fol-
lowing migration of cytochrome c from mitochondria to 
cytosol [5]. Translocation of Bad, a pro-apoptotic protein, 
from cytosol to mitochondria demonstrated the initia-
tion of apoptotic event. BH-3 family members (Bad, Bid, 
Bim, etc.) are well-known pro-apoptotic proteins and 
can change the pro-apoptotic processes by inhibiting the 
transcription levels of anti-apoptotic proteins [2]. Activa-
tion of the extrinsic receptor-mediated pathway induces 
apoptosis by Fas-mediated activation of Bid and cleavage 
of pro-caspase 8 to its cleaved fraction [2]. In the present 
study, immunoblot analysis confirmed the involvement of 
both intrinsic and extrinsic pathways of apoptosis follow-
ing Cd exposure. One potential target of oxidative free 
radicals is P-65 NF-κB. Activation of P-65 NF-κB could 
participate in various toxicological responses via. inflam-
mation as well induction of apoptosis [44]. However, the 
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extracts could significantly interrupt the apoptotic event 
may be by inhibiting ROS.
To validate the in  vitro protective effect of AEIA or 
AEEF, in vivo experimentation was performed. The LD50 
value of CdCl2 has been found to be 4 mg/kg in experi-
mental mice. Therefore, 4  mg/kg dose has been chosen 
for the subsequent experiments. This value is nearly 
equivalent to ~80 µg/day (for 20 g mice), which is inter-
estingly comparable to the exposure at the highly Cd 
polluted locations. The amounts of daily Cd ingestion 
with food in most countries are ranging between 10 and 
20  µg/day [45]. Smoking also potentiates the daily con-
sumption of Cd. Therefore, selected dose could be justi-
fied through the aforementioned points. The effects of 
test extracts were examined by evaluating haematological 
and serum biochemical parameters. Kidney, heart, liver, 
brain and testes are considered to be the potential targets 
of Cd toxicity [5]. Therefore, the biochemical and redox 
markers were analysed for aforementioned tissues along 
with histological investigation to observe the effect of test 
extracts in vivo.
In vivo study revealed that Cd was accumulated mostly 
in kidney and heart followed by liver, brain and mini-
mum quantity in testes. Simultaneous administration of 
extracts and CdCl2 significantly lowered the Cd burden 
in the selected tissues of experimental mice. The experi-
mental outcome indicated that both the extracts could 
promote the clearance of intercellular Cd. The phyto-
chemicals present within the extracts might form soluble 
chelate with Cd and potentiate its clearance from the tis-
sues. Earlier studies revealed the metal chelating activity 
of flavonoids and saponins [5, 42, 46–49]. Therefore, the 
reduction of Cd burden within the tissue may be due to 
presence of significant quantity of flavonoids and sapo-
nins in AEIA and AEEF.
The serum biochemical and haematological param-
eters serve as the earliest indicators of the abnormali-
ties within the system [5]. Considerable reduction in 
total erythrocyte count and haemoglobin content was 
observed in CdCl2-intoxicated mice, which is in accord-
ance to earlier reports [5, 50]. Increased levels of ALT 
and AST in serum indicated the membrane leakage dur-
ing cellular damages in kidneys and livers during Cd-
intoxication [5]. Administration of the extracts along 
with toxin, however, could significantly protect the cel-
lular damage indicated by the reduced levels of afore-
mentioned enzymes in serum. Kidney remained a major 
target in Cd toxicity. An increase in the level of serum 
Fig. 8 Schematic presentation of probable protective mechanism of AEIA and AEIA against Cd toxicity. The black arrows indicate the sequential 
events involved in Cd pathogenesis. The red colour lines (−) indicates inhibitory effect on the events involved in Cd toxicity pathway, while, green 
colour line (+) denotes promoting the process of Cd clearance from the cell.
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urea may be associated by the protein catabolism due 
to nephrotoxic effect of Cd. Elevated levels of serum 
lipids is an indication of increased lipogenesis and/or 
decreased clearance of lipoproteins during Cd-intoxica-
tion. Treatment of AEIA or AEEF could signify the pro-
tective role of extract against Cd toxicity.
In search of effect of AEIA and AEEF on tissue anti-
oxidant markers in vivo, it was found that administration 
of either of extracts along with CdCl2 could significantly 
attenuate the oxidative challenge caused by Cd. The 
in vivo results supported the in vitro findings. Mitochon-
drial co-enzymes Q (Q9 and Q10) play an important role 
as electron carriers. Co-enzymes act as antioxidants by 
scavenging free radicals and inhibiting lipid peroxidation 
[51]. The decreased level of coenzyme Q9 and Q10 sug-
gested the oxidative challenge caused by Cd, which was 
significantly improved by the extracts’ treatment. The 
extracts might exert this effect through promoting Cd 
clearance from the tested organs.
Finally, histological assessments revealed that Cd 
caused abnormal histological changes in the tissues. 
However, pre-treatment with the extracts could attenuate 
these histological changes and restore cyto-architecture 
near-normal status.
Conclusion
Existing literature revealed that, Cd accumulation causes 
redox imbalance which is a principle mechanism in Cd-
toxicity (Fig. 8). Therefore, inhibition of Cd bioaccumu-
lation i.e. promoting Cd clearance and/or counteracting 
with oxidative stress would be the major therapeutic tar-
get. In present investigation, it was found that the admin-
istration of the aqueous extracts of the edible aerial parts 
of I. aquatica and E. fluctuans, individually, attenuated 
toxic manifestations caused by CdCl2. Experimental data 
showed that excess of oxidative free radicals after Cd 
exposure caused oxidative tissue damage and initiation 
of apoptosis by intrinsic as well as extrinsic pathways. 
The results of the present study suggested that both the 
extracts offered protection against Cd-induced toxic-
ity by counteracting oxidative stress and ROS mediated 
apoptosis. The extracts would offer the overall protec-
tive effect via counteracting with Cd mediated oxidative 
stress and/or promoting the elimination of Cd by chelat-
ing (Fig.  8). Phytochemical studies revealed presence of 
flavonoids, phenolic compounds and ascorbic acid in the 
test extracts. Substantial quantities of aforementioned 
dietary antioxidants [52, 53] could contribute in overall 
protection against Cd-intoxication. In conclusion, dietary 
antioxidants would serve as a protective measure against 
heavy metals toxicity and would serve as potential to 
develop new therapy in future without producing count-
able side effect.
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